Extracellular Vesicle Transplantation Is Beneficial for Acute Kidney Injury
Cells · 2024
DOI: 10.3390/cells13161335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Amankeldi A Salybekov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, 1-1370 Okamoto, Kamakura 2478533, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by JSPS KAKENHI fundings, his research was funded by JSPS KAKENHI fundings, JSPS KAKENHI funding.
Abstract (Originalsprache)
Under vasculogenic conditioning, certain pro-inflammatory subsets within peripheral blood mononuclear cells (PBMCs) undergo phenotypic transformation into pro-regenerative types, such as vasculogenic endothelial progenitor cells, M2 macrophages, and regulatory T cells. These transformed cells are collectively termed regeneration-associated cells (RACs). In this study, we aimed to investigate the therapeutic efficacy of RAC-derived extracellular vesicles (RACev) compared with a vehicle-treated group in the context of renal ischemia-reperfusion injury (R-IRI). Human PBMCs were cultured with defined growth factor cocktails for seven days to harvest RACs. EV quantity and size were characterized by nanoparticle tracking analysis. Notably, the systemic injection of RACev significantly decreased serum creatinine and blood urine nitrogen at day three compared to the control group. Histologically, the treatment group showed less fibrosis in the cortex and medullary areas (p < 0.04 and p < 0.01) compared to the control group. The CD31 staining confirmed enhanced capillary densities in the treatment group compared to the control group (p < 0.003). These beneficial effects were accompanied by angiogenesis, anti-fibrosis, anti-inflammation, and anti-apoptosis RACev miR delivery to ischemic injury to control inflammatory, endothelial mesenchymal transition, and hypoxia pathways. In vivo bioluminescence analysis demonstrated a preferential accumulation of RACev in the IR-injured kidney. The systemic transplantation of RACev beneficially restored kidney function by protecting from tissue fibrosis and through anti-inflammation, angiogenesis, and anti-apoptosis miR delivery to the ischemic tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, 1-1370 Okamoto, Kamakura 2478533, Japan.
- Shonan Research Institute of Innovative Medicine, Shonan Kamakura General Hospital, 1-1370 Okamoto, Kamakura 2478533, Japan.
- Division of Regenerative Medicine, Department of Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Okamoto 1-1370, Kamakura 2478533, Japan.
ORCID-Profile: Amankeldi A Salybekov, Takayasu Ohtake, Sumi Hidaka
Förderung
- This research was funded by JSPS KAKENHI fundings
- his research was funded by JSPS KAKENHI fundings
- JSPS KAKENHI funding
Zitieren
APA
Salybekov, A. A., Okamura, S., Ohtake, T., Hidaka, S., Asahara, T., & Kobayashi, S. (2024). Extracellular Vesicle Transplantation Is Beneficial for Acute Kidney Injury. Cells. https://doi.org/10.3390/cells13161335
Vancouver
Salybekov AA, Okamura S, Ohtake T, Hidaka S, Asahara T, Kobayashi S. Extracellular Vesicle Transplantation Is Beneficial for Acute Kidney Injury. Cells. 2024. doi:10.3390/cells13161335
BibTeX
@article{Salybekov2024,
author = {Salybekov, Amankeldi A and Okamura, Shigeaki and Ohtake, Takayasu and Hidaka, Sumi and Asahara, Takayuki and Kobayashi, Shuzo},
title = {Extracellular Vesicle Transplantation Is Beneficial for Acute Kidney Injury},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13161335}
}
EUVIMED